Nectar Life Sciences Limited - Due diligence report
A 360° intelligence report on Neclife: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Neclife — 360° Intelligence Report
Generated from MCA filings & public recordsNeclife is assessed as Moderate with a Trust Score of 64/100. Neclife is an active public limited indian non-government company incorporated in 1995, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.
Report generated on 07 Jul 2026 from the latest processed filings. Nectar Life Sciences Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Externally credit-rated (D).
Charges position: 0 open (-) · 111 satisfied (6,249.44 cr).
| Lender | Charges | Amount |
|---|---|---|
| Others | 9 | 48.0 cr |
| Sbicap Trustee Company Limited | 1 | 48.0 cr |
| Punjab National Bank | 17 | 48.0 cr |
| State Bank Of India | 10 | 48.0 cr |
| Export-Import Bank Of India | 6 | 48.0 cr |
| Ifci Limited | 3 | 48.0 cr |
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE.
- Litigation present in 3 court forum(s).
- Delayed payments to MSME suppliers disclosed (3 disclosure(s)).
- 5 active GST registration(s).
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RUPINDER TEWARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJIV GOYAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| INDU PAL KAUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KULDIP KUMAR BHASIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUSHIL KAPOOR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Surulichamy Senthilkumar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sanjaymohan Singh Rawat | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sushil Kapoor | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2025 annual returnPromoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Neclife Pt, Unipessoal Lda, Portugal | Subsidiary Company | 74.00% |
Key managerial personnel: SANJIV GOYAL (Managing Director) · SUSHIL KAPOOR (CFO) · Surulichamy Senthilkumar (Whole-time director)
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 55 · Distress 60Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Laborate Pharmaceuticals India | U24239HR1990PLC030835 | Haryana, Haryana, India |
| Drmorepen | L24231HP1984PLC006028 | Himachal Pradesh, Himachal Pradesh, India |
| Alkyl Amines | L99999MH1979PLC021796 | New Mumbai, Maharashtra, India |
| Karnataka Soaps And Detergents Limited | U85110KA1980SGC003871 | Bangalore, Karnataka, India |
| Moil | L99999MH1962GOI012398 | Nagpur, Maharashtra, India |
| Leefordcosmacia | U24230PB2006PLC029786 | Ludhiana, Punjab, India |
| Bodal | L24110GJ1986PLC009003 | Daskroi, Gujarat, India |
| Navin Fluorine | L24110MH1998PLC115499 | Mumbai, Maharashtra, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Neclife before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Neclife: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Neclife - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Neclife pays its suppliers before you extend credit terms.
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Neclife - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Neclife an active company?
Neclife has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).
Is Neclife financially healthy?
Neclife has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.
Should I do business with Neclife?
Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Neclife?
Promoters hold a minority stake - exact percentages are in the full report. 8 active director(s) are on record.
Does Neclife have loans or charges against its assets?
No open charges - all 111 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Neclife up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).
Is it risky to lend to Neclife?
Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.